SSNSESensei Biotherapeutics Inc

Sensei Biotherapeutics Inc

SNSE

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive SNSE chart

  • Mkt cap

    $18.59M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue (FY2025)

    N/A

  • EPS (H1 2026)

    $-53.50

  • Gross Margin (FY2025)

    N/A

  • Profit Margin (FY2025)

    N/A

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

Live SNSE terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

SNSE — Sensei Biotherapeutics Inc · $18.6M cap

SNSE Key Statistics

  • Market Cap: $18.6M
  • P/B Ratio: 1.26

Sensei Biotherapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full SNSE income, balance, and cash tables.

  • Net Income-$21.1M
  • Total Assets$22.9M
  • Free Cash Flow-$20.5M

SNSE recent filings

SNSE FAQ

What industry is SNSE in?

Sensei Biotherapeutics Inc (SNSE) is a biotechnology company in the Healthcare sector.

What is SNSE's latest net income?

Latest cached Sensei Biotherapeutics Inc (SNSE) net income for FY2025 was -$21.1M. Statements: https://lician.com/financials/snse

What is SNSE's market cap?

Sensei Biotherapeutics Inc (SNSE) market capitalization is $18.6M on the latest cached snapshot.

What is the latest SNSE SEC filing?

The latest cached SNSE filing is 8-K · Jun 18, 2026. Filings: https://lician.com/sec/snse

Live SNSE terminal loads when you scroll near this section.